个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Clinical practice guidelines for the management of adult diffuse gliomas

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Tao Jiang[1,2,3,4,5,*1] ; Do-Hyun Nam[6,*2] ; Zvi Ram[7,*3] ; Wai-sang Poon[8,*4] ; Jiguang Wang[9,*5] ; DamdindorjBoldbaatar[10,*6] ; Ying Mao[11,*7] ; Wenbin Ma[12,*8] ; Qing Mao[13,*9] ; Yongping You[14,*10] ; Chuanlu Jiang[15,*11] ; Xuejun Yang[16,*12] ; Chunsheng Kang[16] ; Xiaoguang Qiu[17] ; Wenbin Li[2] ; Shaowu Li[1] ; Ling Chen[18] ; XuejunLi[19] ; Zhixiong Liu[19] ; Weimin Wang[20] ; Hongmin Bai[20] ; Yu Yao[10] ; Shouwei Li[21] ; Anhua Wu[22] ; Ke Sai[23] ; Guilin Li[1] ; Kun Yao[24] ; Xinting Wei[25] ; Xianzhi Liu[25] ; Zhiwen Zhang[26] ; Yiwu Dai[27] ; Shengqing Lv[28] ; Liang Wang[29] ; Zhixiong Lin[21] ; Jun Dong[30] ; Guozheng Xu[31] ; Xiaodong Ma[18] ; Wei Zhang[2,4] ; ChuanbaoZhang[2] ; Baoshi Chen[2] ; Gan You[2] ; Yongzhi Wang[2] ; Yinyan Wang[2] ; Zhaoshi Bao[2] ; Pei Yang[2] ; Xing Fan[1] ; Xing Liu[1] ; Zheng Zhao[1] ; Zheng Wang[2] ; Yiming Li[2] ; Zhiliang Wang[2] ; Guanzhang Li[1] ; Shengyu Fang[1] ; Lianwang Li[1] ; Yanwei Liu[17] ; Shuai Liu[17] ; Xia Shan[17] ; Yuqing Liu[1] ; Ruich o Chai[1] ; Huimin Hu[1] ; JingChen[1] ; Wei Yan[14] ; Jinquan Cai[15] ; Hongjun Wang[15] ; Lingchao Chen[11] ; Yuan Yang[13] ; Yu Wang[12] ; LeiHan[16] ; Qixue Wang[16] ;
机构： [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China [2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing100070, China [3]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing 100070, China [4]China National Clinical Research Center for Neurological Diseases, Beijing 100070, China [5]Research Units of Accurate Diagnosis and Treatment of Brain Tumors and TranslationalMedicine, Chinese Academy of Medical Sciences, Beijing, 100730, China [6]Departmen of Neurosurgery, Samsung Medical Center, Korea [7]Department o Neurosurgery, Tel Aviv Medical Center, Israel [8]Department of Neurosurgery, The Chinese University of Hong Kong, Prince of WalesHospital, Hong Kong, China [9]Division of Life Science, Department of Chemical and Biological Engineering, Hong KongUniversity of Science and Technology, Hong Kong, China [10]Department of Physiology, School of Biomedicine, Mongolian National University of Medical Sciences [11]Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040,China [12]Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100730, China [13]Department of Neurosurgery, West China Hospital, West China Medical School, SichuanUniversity, Chengdu 610041, China [14]Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029, China [15]Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University,Harbin 150086, China [16]Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin300052, China [17]Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University,Beijing 100070, China [18]Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China [19]Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha,Hunan 410008, China [20]Department of Neurosurgery, General Hospital of Southern Theatre Command,Guangzhou 510010, China [21]Department of Neurosurgery, San Bo Brain Hospital, Capital Medical University, Beijing100093, China [22]Department of Neurosurgery, The First Affiliated Hospital of China Medical University,Shenyang 110001, China [23]Department of Neurosurgery, Sun Yat-Sen University Can er Center, Guangzhou 510060,China [24]Department of Pathology, San Bo Brain Hospita , Capital Medical University, Beijing100093, China [25]Department of Neurosurgery, The 1st Affiliated Hospital of Zhengzhou University,Zhengzhou 450052, China [26]Department of Neurosurgery, The Fourth Medical Center of PLA General Hospital, Beijing100048, China [27]Department of Neurosurgery The Seventh Medical Center of PLA General Hospital,Beijing 100700, China [28]Department of Neu osurgery, Xinqiao Hospital, Army Medical University, Chongqing400038, China [29]Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an710038, China [30]Departmen of Neurosurgery, Medical College of Soochow University, Suzhou 215123,China [31]Department of Neurosurgery, General Hospital of Central Theatre Command, Wuhan430070, China
出处：
DOI： 10.1016/j.canlet.2020.10.050
ISSN：

关键词： Chemoradiation Immune therapy Molecular diagnostics Surgery Target therapy

摘要：
To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries. © 2020 Elsevier B.V.

基金：
This work was supported by grants from 1. National Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) Joint Research Scheme ( 81761168038 ); 2. Beijing Municipal Administration of Hospitals’ Mission Plan ( SML20180501 ); 3. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences ( 2019-I2M-5–021 ); 4. National Natural Science Foundation of China ( 81672479 , 81773208 , 81702460 , 81871013 , 81802483 , 81972337 , 81902528 , 81903060 , 81903078 , 81972816 ); 5. The National Key Research and Development Program of China ( 2018YFC0115604 ).
语种：
外文
高被引：
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 2 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China [2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing100070, China [3]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing 100070, China [4]China National Clinical Research Center for Neurological Diseases, Beijing 100070, China [5]Research Units of Accurate Diagnosis and Treatment of Brain Tumors and TranslationalMedicine, Chinese Academy of Medical Sciences, Beijing, 100730, China [*1]Beijing Neurosurgical Institute, Capital Medical University. No.119, South 4th Ring Road West, Fengtai District, Beijing 100070, China.
通讯作者：
通讯机构： [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China [2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing100070, China [3]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing 100070, China [4]China National Clinical Research Center for Neurological Diseases, Beijing 100070, China [5]Research Units of Accurate Diagnosis and Treatment of Brain Tumors and TranslationalMedicine, Chinese Academy of Medical Sciences, Beijing, 100730, China [6]Departmen of Neurosurgery, Samsung Medical Center, Korea [7]Department o Neurosurgery, Tel Aviv Medical Center, Israel [8]Department of Neurosurgery, The Chinese University of Hong Kong, Prince of WalesHospital, Hong Kong, China [9]Division of Life Science, Department of Chemical and Biological Engineering, Hong KongUniversity of Science and Technology, Hong Kong, China [10]Department of Physiology, School of Biomedicine, Mongolian National University of Medical Sciences [11]Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040,China [12]Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100730, China [13]Department of Neurosurgery, West China Hospital, West China Medical School, SichuanUniversity, Chengdu 610041, China [14]Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029, China [15]Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University,Harbin 150086, China [16]Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin300052, China [*1]Beijing Neurosurgical Institute, Capital Medical University. No.119, South 4th Ring Road West, Fengtai District, Beijing 100070, China. [*2]Department of Neurosurgery, Samsung Medical Center, Korea [*3]Department of Neurosurgery, Tel Aviv Medical Center, Israel [*4]Department of Neurosurgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China [*5]Division of Life Science, Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, Hong Kong, China. [*6]Department of Physiology, School of Biomedicine, Mongolian National University of Medical Sciences. [*7]Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China [*8]Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China [*9]Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China [*10]Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. [*11]Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China [*12]Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China
推荐引用方式(GB/T 7714)：
Tao Jiang,Do-Hyun Nam,Zvi Ram,et al.Clinical practice guidelines for the management of adult diffuse gliomas[J].CANCER LETTERS.2021,499:60-72.doi:10.1016/j.canlet.2020.10.050.
APA：
Tao Jiang,Do-Hyun Nam,Zvi Ram,Wai-sang Poon,Jiguang Wang...&Qixue Wang.(2021).Clinical practice guidelines for the management of adult diffuse gliomas.CANCER LETTERS,499,
MLA：
Tao Jiang,et al."Clinical practice guidelines for the management of adult diffuse gliomas".CANCER LETTERS 499.(2021):60-72

相关文献

[1]The CRISPR-Cas system in molecular diagnostics [2]Necroptosis in the sarcoma immune microenvironment: From biology to therapy [3]Diagnostic yield and clinical impact of exome sequencing in early-onset scoliosis (EOS). [4]Upfront surgery and postoperative chemoradiation when needed strategy in locally advanced esophageal squamous cell carcinoma [5]女性阴道感染性疾病与HR-HPV感染的相关关系 [6]NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China [7]A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy [8]Molecular analysis of phenotypic heterogeneity in JAK2V617F-positive myeloproliferative neoplasms reveals a potential target for therapy [9]Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. [10]激素受体阳性乳腺癌靶向治疗进展

资源点击量：43389 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号